Dear AuntMinnie Member,
It's the radiology awards event you've been waiting for -- the 2021 Minnies -- and it's now open for nominations!
Now in its 22nd year, the Minnies enable AuntMinnie.com members to acknowledge the people, products, and programs that deserve recognition for excellence in medical imaging. The Minnies cover 14 categories, ranging from Most Influential Radiology Researcher to Best Radiology Image. Other categories cover devices, software, mobile apps, and more.
But the Minnies wouldn't amount to much without your help. Let us know who you think should be in the running for radiology's most prestigious award by filling out our short nominations survey. You can pick a colleague you admire, a product that's delighted you, or your favorite radiology education program.
More information is available at minnies.auntminnie.com.
MRI for prostate screening
When you're done filling out the nominations form, come back to AuntMinnie.com for some of our regularly scheduled programming, such as our top story for the past week. Swedish researchers found that using MRI to see which men with high prostate-specific antigen (PSA) scores should be sent on for biopsy finds cancers and also reduces unnecessary biopsies.
Meanwhile, a group from New York City tested a deep-learning algorithm that detected axillary lymph node metastasis on multiparametric MRI exams of breast cancer patients, while another New York group investigated MRI to track soft-tissue complications in patients undergoing hip procedures.
Get these stories and more in our MRI Community.
AI of COVID outcomes
Since the COVID-19 pandemic began, researchers have been investigating how to use artificial intelligence (AI) to help detect disease and predict patient outcomes.
One of our top stories for the past week does just that, describing how an AI algorithm predicted patient outcomes by analyzing body composition metrics. The beauty of the research is that the algorithm works by analyzing CT scans acquired for other purposes.
Meanwhile, researchers from Hong Kong developed an AI model that identifies SARS-CoV-2 infection from blood tests and chest x-rays. Finally, internet services giant Amazon this week announced the availability of its HealthLake cloud-based data repository, which the company believes will spur development of new technologies in clinical care and life sciences research.